Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
528,900
-
Share change
-
+34,170
-
Total reported value
-
$98,242,898
-
Price per share
-
$185.74
-
Number of holders
-
98
-
Value change
-
+$6,457,088
-
Number of buys
-
41
-
Number of sells
-
37
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2021
As of 30 Jun 2021,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
528,900 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, MORGAN STANLEY, CITADEL ADVISORS LLC, BROWN ADVISORY INC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, UBS Group AG, and MURPHY CAPITAL MANAGEMENT INC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.